-
Influenza Pipeline Insights, Clinical Trials Analysis, Emerging Therapies and Companies | DelveInsight
20 Jan 2025 12:39 GMT
… Group Corporation, Poolbeg Pharma, MYMETICS, CELLTRION INC., Avalia Immunotherapies … companies with DelveInsight @ Influenza Treatment Drugs
Influenza Emerging Drugs
• … Group Corporation, Poolbeg Pharma, MYMETICS, CELLTRION INC., Avalia Immunotherapies …
-
Influenza Pipeline Assessment – FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies by DelveInsight
02 Sep 2022 21:50 GMT
… PDF Report for Influenza pipeline assessment– Influenza Therapeutics Assessment
… Group Corporation, Poolbeg Pharma, MYMETICS, CELLTRION INC., Avalia Immunotherapies … . Influenza Unmet Needs
18. . Influenza Future Perspectives
19. . Influenza Analyst Review …
-
World Vaccines (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others) Market Analysis 2018
17 Sep 2018 08:06 GMT
… Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, … Cholera
Diphtheria-Tetanus
Ebola
Hepatitis
Influenza
Japanese Encephalitis
Nosocomial Infections
…
Merck & Co. Inc.
Mymetics
PaxVax
Pfizer
Sanofi Pasteur
Serum …
-
Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast...
23 Apr 2018 08:40 GMT
… CEO of Anergis.
About Mymetics
Mymetics Corporation (OTCQB:MYMX) … 47;AIDS, intra-nasal Influenza, Malaria, Chikungunya, Herpes … malaria and
intra-nasal influenza vaccines have successfully finished … of treatment.
CONTACTS:
Mymetics Corporation
Ronald Kempers
…
-
Mymetics to Present New Preclinical Data on Thermostable and Cold-Chain Independent Virosome based Vaccines
13 Sep 2017 12:21 GMT
… . HIV, malaria and intra-nasal influenza vaccines have successfully finished Phase … combination with rationally designed antigens. Mymetics' vaccines are designed to … -pharmaceutical virosome-based vaccine candidates.
Mymetics acts as coordinator and works …
-
Mymetics' HIV Vaccine Candidate Confirms Promise in Preclinical Study With the Texas Biomedical Research Institute
11 Apr 2016 07:36 GMT
… are well documented.
About Mymetics
Mymetics Corporation (OTCQB: MYMX) … vaccines for infectious diseases. Mymetics' core technology … 1/AIDS, intranasal Influenza, Malaria, Herpes Simplex Virus … company's intranasal Influenza vaccine and the HIV …
-
Mymetics Announces Successful Preclinical Results With Malaria Transmission-Blocking Vaccine Candidate
05 Apr 2016 06:53 GMT
… malaria transmission-blocking vaccine constructs.
Mymetics has shown separately in 2011 … and treating these illnesses.
About Mymetics
Mymetics Corporation (OTCQB: MYMX) is a … -nasal Influenza, Malaria, Herpes Simplex Virus and the RSV vaccine.
Mymetics…
-
Mymetics Announces Discontinuation of the RSV Collaborative Project
29 Jan 2016 03:25 GMT
… respectively. In addition, Mymetics has an intra-nasal influenza virosome vaccine that … to facilitate this transfer.
About Mymetics
Mymetics Corporation (OTCQB: MYMX) is a … -nasal Influenza, Malaria, Herpes Simplex Virus and the RSV vaccine.
Mymetics…
-
Mymetics-Led Consortium Awarded €8.4 Million for Development of Thermo Stable and Cold-Chain ...
20 Apr 2015 07:40 GMT
… Agreement No 646122.
About Mymetics
Mymetics Corporation (OTCQB: MYMX) … Influenza, Malaria, Herpes Simplex Virus and the RSV vaccine.
Mymetics … stage marketplace.
Contacts
Mymetics Corporation
Ronald Kempers
CEO …
About
© 1995-2025